05 October 2022
Amendments to Russia’s laws concerning the production of vital and essential drugs (VED) from blood plasma came into force on October 1. This is reported on the website of the State Duma.
“Russian pharmaceutical companies that use blood plasma for the production of vital and essential drugs will no longer depend on imported raw materials and will receive the necessary components faster. It is also prohibited to export donated blood received in Russia outside the country, with the exception of humanitarian aid,” the message says.
It is also allowed to import plasma into the Russian Federation for the production of drugs and medical devices in compliance with the EAEU rules.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Health Ministry registered Russian drug for ankylosing spondylitis
06 May 2024
How gut enzymes could make universal donor blood possible
06 May 2024
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024